\-\ Texto\\:\\ \ \(0\)\
\-\ diffuse\\ abdominal\\ pain\\.\ \(7\)\
\-\ ct\\ shows\\ gynecomastia\\,\\ and\\ a\\ nodular\\/lobulated\\ liver\\.\ \(0\)\
\-\ gynecomastia\\ secondary\\ to\\ cardiac\\ cirrhosis\\(secondary\\ to\\ chf\\)\\ and\\ digitalis\\ use\\.\ \(0\)\
\-\ ddx\\ of\\ gynecomastia\\:\\ \ \(0\)\
\-\ cirrhosis\\,\\ obesity\\,\\ digitalis\\,\\ estrogen\\,\\ spironolactone\\.\ \(1\)\
\-\ pt\\ is\\ a\\ 80\\ year\\ old\\ male\\ with\\ a\\ pmhx\\ significant\\ for\\ chronic\\ a\\-fib\\,\\ chf\\,\\ gout\\,\\ ra\\,\\ avn\\ of\\ the\\ hips\\,\\ cri\\,\\ and\\ bph\\,\\ who\\ presented\\ to\\ the\\ ed\\ with\\ a\\ cc\\ of\\ right\\ sided\\ abdominal\\ pain\\.\\ \\ medications\\ are\\ extensive\\,\\ but\\ include\\ digitalis\\.\ \(0\)\
\-\ case\\ is\\ mainly\\ for\\ discussion\\.\\ \\ one\\ can\\ also\\ discuss\\ the\\ ddx\\ of\\ cirrhosis\\ which\\ is\\ extensive\\:\ \(0\)\
\-\ 1\\.toxic\\:\\ alcoholic\\ liver\\ disease\\;\\ drugs\\:methotrexate\\,isoniazid\\;\\ iron\\ overload\\.\ \(1\)\
\-\ 2\\.\\ inflammation\\:\\ hepatitis\\,\\ schistosomiasis\\.\ \(1\)\
\-\ 3\\.\\ biliary\\ obstruction\\:\\ cystic\\ fibrosis\\,\\ inflammatory\\ bowel\\ disease\\,\\ primary\\ biliary\\ cirrhosis\\,\\ obstructive\\ infantile\\ cholangiopathy\\.\ \(1\)\
\-\ 4\\.\\ vascular\\:\\ prolonged\\ chf\\,\\ budd\\-chiari\\ syndrome\\.\ \(0\)\
\-\ 5\\.\\ nutritional\\:\\ intestinal\\ bypass\\,\\ severe\\ steatosis\\,\\ abetalipoproteinemia\\.\ \(1\)\
\-\ 6\\.\\ hereditary\\:\\ wilson\\ disease\\,\\ alpha\\-1\\ antitrypsin\\ deficiency\\,\\ galactosemia\\,\\ type\\ iv\\ glycogen\\ storage\\ disease\\,\\ hereditary\\ fructose\\ intolerance\\,\\ tyrosinemia\\,\\ hereditary\\ tetany\\,\\ osler\\-weber\\-rendu\\ syndrome\\,\\ familial\\ cirrhosis\\.\ \(0\)\
\-\ 7\\.\\ idiopathic\\/cryptogenic\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cirrhosis\\:\\ 0\\.12036671746526882\ \(0\)\
\-\ digitalis\\:\\ 0\\.11076898758801515\ \(0\)\
\-\ gynecomastia\\:\\ 0\\.09860681734322276\ \(0\)\
\-\ chf\\:\\ 0\\.07679113666746562\ \(0\)\
\-\ hereditary\\:\\ 0\\.07038510170150744\ \(0\)\
\-\ \\:\\:\\ 0\\.04867212126275591\ \(0\)\
\-\ ddx\\:\\ 0\\.04317180220825194\ \(0\)\
\-\ nodular\\/lobulated\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ 1\\.toxic\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ alpha\\-1\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ galactosemia\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ tyrosinemia\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ idiopathic\\/cryptogenic\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ biliary\\:\\ 0\\.04129864836015534\ \(0\)\
\-\ spironolactone\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ cri\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ steatosis\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ abetalipoproteinemia\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ antitrypsin\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ fructose\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ tetany\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ \\,\\:\\ 0\\.03756264066986284\ \(0\)\
\-\ cholangiopathy\\:\\ 0\\.03692299586267171\ \(0\)\
\-\ a\\-fib\\:\\ 0\\.035546526616490944\ \(0\)\
\-\ osler\\-weber\\-rendu\\:\\ 0\\.035546526616490944\ \(0\)\
\-\ bph\\:\\ 0\\.03447885412216458\ \(0\)\
\-\ isoniazid\\:\\ 0\\.03447885412216458\ \(0\)\
\-\ glycogen\\:\\ 0\\.03286893911440758\ \(0\)\
\-\ extensive\\:\\ 0\\.03270196863587316\ \(0\)\
\-\ budd\\-chiari\\:\\ 0\\.03116236043527489\ \(0\)\
\-\ nutritional\\:\\ 0\\.03116236043527489\ \(0\)\
\-\ estrogen\\:\\ 0\\.030290008488892333\ \(0\)\
\-\ alcoholic\\:\\ 0\\.030290008488892333\ \(0\)\
\-\ schistosomiasis\\:\\ 0\\.030290008488892333\ \(0\)\
\-\ overload\\:\\ 0\\.029907029026339526\ \(0\)\
\-\ storage\\:\\ 0\\.029552445427517893\ \(0\)\
\-\ liver\\:\\ 0\\.028193507280695917\ \(0\)\
\-\ avn\\:\\ 0\\.028091289209569655\ \(0\)\
\-\ discuss\\:\\ 0\\.027389837179943456\ \(0\)\
\-\ wilson\\:\\ 0\\.027389837179943456\ \(0\)\
\-\ disease\\:\\ 0\\.026731818970635486\ \(0\)\
\-\ infantile\\:\\ 0\\.026590535339449835\ \(0\)\
\-\ mainly\\:\\ 0\\.026068050688899634\ \(0\)\
\-\ methotrexate\\:\\ 0\\.026068050688899634\ \(0\)\
\-\ iron\\:\\ 0\\.025748953203260056\ \(0\)\
\-\ obesity\\:\\ 0\\.02559704555582187\ \(0\)\
\-\ intolerance\\:\\ 0\\.025449812739234533\ \(0\)\
\-\ bypass\\:\\ 0\\.025306975594977688\ \(0\)\
\-\ familial\\:\\ 0\\.025033490361293723\ \(0\)\
\-\ pmhx\\:\\ 0\\.024183341187908783\ \(0\)\
\-\ hips\\:\\ 0\\.024073343493053765\ \(0\)\
\-\ hepatitis\\:\\ 0\\.023461700567169147\ \(0\)\
\-\ syndrome\\:\\ 0\\.023386665806073122\ \(0\)\
\-\ intestinal\\:\\ 0\\.023182901963705153\ \(0\)\
\-\ gout\\:\\ 0\\.02291945805373851\ \(0\)\
\-\ secondary\\:\\ 0\\.02286153077998859\ \(0\)\
\-\ drugs\\:\\ 0\\.02258934862078659\ \(0\)\
\-\ ra\\:\\ 0\\.022355902859210363\ \(0\)\
\-\ deficiency\\:\\ 0\\.022061367486007333\ \(0\)\
\-\ cc\\:\\ 0\\.021920631193154252\ \(0\)\
\-\ 7\\.\\:\\ 0\\.02178391649246499\ \(0\)\
\-\ prolonged\\:\\ 0\\.02171699667440403\ \(0\)\
\-\ obstructive\\:\\ 0\\.021036735962535406\ \(0\)\
\-\ abdominal\\:\\ 0\\.020439418546623112\ \(0\)\
\-\ 6\\.\\:\\ 0\\.01986640827681546\ \(0\)\
\-\ \\;\\:\\ 0\\.019382020942130082\ \(0\)\
\-\ 80\\:\\ 0\\.019233147743395965\ \(0\)\
\-\ discussion\\:\\ 0\\.019154708462172633\ \(0\)\
\-\ medications\\:\\ 0\\.01823718716756478\ \(0\)\
\-\ fibrosis\\:\\ 0\\.018205182439570537\ \(0\)\
\-\ 5\\.\\:\\ 0\\.01763454406240873\ \(0\)\
\-\ inflammation\\:\\ 0\\.017386291261600063\ \(0\)\
\-\ ed\\:\\ 0\\.017279960463587093\ \(0\)\
\-\ use\\:\\ 0\\.01615999576575743\ \(0\)\
\-\ 4\\.\\:\\ 0\\.016097990288999033\ \(0\)\
\-\ cardiac\\:\\ 0\\.015573381784454403\ \(0\)\
\-\ pt\\:\\ 0\\.01520174045278829\ \(0\)\
\-\ sided\\:\\ 0\\.015117352216012658\ \(0\)\
\-\ iv\\:\\ 0\\.014920693480675089\ \(0\)\
\-\ obstruction\\:\\ 0\\.014418182050667154\ \(0\)\
\-\ inflammatory\\:\\ 0\\.014178545187521645\ \(0\)\
\-\ 3\\.\\:\\ 0\\.013989828766223575\ \(0\)\
\-\ type\\:\\ 0\\.013782891044722058\ \(0\)\
\-\ vascular\\:\\ 0\\.013405757262792806\ \(0\)\
\-\ 2\\.\\:\\ 0\\.01300212508038401\ \(0\)\
\-\ bowel\\:\\ 0\\.0128227441764821\ \(0\)\
\-\ severe\\:\\ 0\\.012580429665387579\ \(0\)\
\-\ diffuse\\:\\ 0\\.012378025934810119\ \(0\)\
\-\ primary\\:\\ 0\\.01211188642533826\ \(0\)\
\-\ cystic\\:\\ 0\\.011792500991635207\ \(0\)\
\-\ chronic\\:\\ 0\\.011516696808167463\ \(0\)\
\-\ include\\:\\ 0\\.01146963391402051\ \(0\)\
\-\ shows\\:\\ 0\\.011241022486741047\ \(0\)\
\-\ presented\\:\\ 0\\.011145251842212484\ \(0\)\
\-\ one\\:\\ 0\\.011080054465601168\ \(0\)\
\-\ significant\\:\\ 0\\.010994483976335996\ \(0\)\
\-\ who\\:\\ 0\\.010660135928907665\ \(0\)\
\-\ pain\\:\\ 0\\.009986681029002246\ \(0\)\
\-\ can\\:\\ 0\\.00927379116013909\ \(0\)\
\-\ case\\:\\ 0\\.008944997286446271\ \(0\)\
\-\ but\\:\\ 0\\.008720111488198744\ \(0\)\
\-\ is\\:\\ 0\\.008071159498345344\ \(0\)\
\-\ also\\:\\ 0\\.008060380830957661\ \(0\)\
\-\ which\\:\\ 0\\.007632270752356692\ \(0\)\
\-\ a\\:\\ 0\\.0075904268290641385\ \(0\)\
\-\ male\\:\\ 0\\.007393327932475948\ \(0\)\
\-\ for\\:\\ 0\\.006977111470265216\ \(0\)\
\-\ to\\:\\ 0\\.006130164236023726\ \(0\)\
\-\ ct\\:\\ 0\\.005719156236325564\ \(0\)\
\-\ are\\:\\ 0\\.005573559198706228\ \(0\)\
\-\ year\\:\\ 0\\.004574666360157487\ \(0\)\
\-\ right\\:\\ 0\\.004314027316317783\ \(0\)\
\-\ old\\:\\ 0\\.004186289937139974\ \(0\)\
\-\ \\(\\:\\ 0\\.0034562762021237343\ \(0\)\
\-\ \\)\\:\\ 0\\.0034140559431258617\ \(0\)\
\-\ and\\:\\ 0\\.0025838613262997865\ \(0\)\
\-\ \\.\\:\\ 0\\.0023779593558031\ \(0\)\
\-\ of\\:\\ 0\\.002229737814315568\ \(0\)\
\-\ the\\:\\ 0\\.00198443949335348\ \(0\)\
\-\ with\\:\\ 0\\.0011196571874630596\ \(0\)\
